Literature DB >> 28379344

A score model to predict risk of events in patients with Brugada Syndrome.

Juan Sieira1, Giulio Conte1, Giuseppe Ciconte1, Gian-Battista Chierchia1, Ruben Casado-Arroyo1, Giannis Baltogiannis1, Giacomo Di Giovanni1, Yukio Saitoh1, Justo Juliá1, Giacomo Mugnai1, Mark La Meir2, Francis Wellens2, Jens Czapla2, Gudrun Pappaert1, Carlo de Asmundis1, Pedro Brugada1.   

Abstract

AIMS: Risk stratification in Brugada Syndrome (BS) remains challenging. Arrhythmic events can occur life-long and studies with long follow-ups are sparse. The aim of our study was to investigate long-term prognosis and risk stratification of BS patients. METHODS AND
RESULTS: A single centre consecutive cohort of 400 BS patients was included and analysed. Mean age was 41.1 years, 78 patients (19.5%) had a spontaneous type I electrocardiogram (ECG). Clinical presentation was aborted sudden cardiac death (SCD) in 20 patients (5.0%), syncope in 111 (27.8%) and asymptomatic in 269 (67.3%). Familial antecedents of SCD were found in 184 individuals (46.0%), in 31 (7.8%) occurred in first-degree relatives younger than 35 years. An implantable cardioverter defibrillator (ICD) was placed in 176 (44.0%). During a mean follow-up of 80.7 months, 34 arrhythmic events occurred (event rate: 1.4% year). Variables significantly associated to events were: presentation as aborted SCD (Hazard risk [HR] 20.0), syncope (HR 3.7), spontaneous type I (HR 2.7), male gender (HR 2.7), early SCD in first-degree relatives (HR 2.9), SND (HR 5.0), inducible VA (HR 4.7) and proband status (HR 2.1). A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. A score greater than 2 conferred a 5-year event probability of 9.2%.
CONCLUSIONS: BS patients remain at risk many years after diagnosis. Early SCD in first-degree relatives and SND are risk factors for arrhythmic events. A simple risk score might help in the stratification and management of BS patients. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Clinical characterization ; Prognosis ; Risk stratification ; Sudden cardiac death;  Brugada syndrome

Mesh:

Year:  2017        PMID: 28379344     DOI: 10.1093/eurheartj/ehx119

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

1.  Outcome of Insertable Cardiac Monitors in Symptomatic Patients with Brugada Syndrome at Low Risk of Sudden Cardiac Death.

Authors:  Rafi Sakhi; Amira Assaf; Dominic A M J Theuns; Judith M A Verhagen; Tamas Szili-Torok; Jolien W Roos-Hesselink; Sing-Chien Yap
Journal:  Cardiology       Date:  2020-04-22       Impact factor: 1.869

2.  Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.

Authors:  Tomas Robyns; Dieter Nuyens; Bert Vandenberk; Cuno Kuiperi; Anniek Corveleyn; Jeroen Breckpot; Christophe Garweg; Joris Ector; Rik Willems
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-30       Impact factor: 1.468

Review 3.  [Brugada syndrome : Risk stratification and prevention of sudden cardiac death].

Authors:  Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2020-01-31

4.  Electrocardiographic Markers Indicating Right Ventricular Outflow Tract Conduction Delay as a Predictor of Major Arrhythmic Events in Patients With Brugada Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Mohammad Iqbal; Iwan Cahyo Santosa Putra; Raymond Pranata; Michael Nathaniel Budiarso; Miftah Pramudyo; Hanna Goenawan; Mohammad Rizki Akbar; Arief Sjamsulaksan Kartasasmita
Journal:  Front Cardiovasc Med       Date:  2022-06-17

5.  For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.

Authors:  Ivaylo Tonchev; David Luria; David Orenstein; Chaim Lotan; Yitschak Biton
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

Review 6.  [Syncopes and channelopathies].

Authors:  Johanna Müller-Leisse; Christos Zormpas; Thorben König; David Duncker; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-15

7.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

Review 8.  Risk Stratification in Brugada Syndrome: Current Status and Emerging Approaches.

Authors:  Shohreh Honarbakhsh; Rui Providencia; Pier D Lambiase
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

Review 9.  [Prevention of sudden cardiac death].

Authors:  Alireza Sepehri Shamloo; Patrick Dilk; Nikolaos Dagres
Journal:  Herz       Date:  2022-03-11       Impact factor: 1.443

10.  Long-term prognosis in patients with non-type 1 Brugada electrocardiogram: Results from a large Japanese cohort of idiopathic ventricular fibrillation.

Authors:  Tetsuji Shinohara; Masahiko Takagi; Tsukasa Kamakura; Yukio Sekiguchi; Yasuhiro Yokoyama; Naohiko Aihara; Masayasu Hiraoka; Kazutaka Aonuma
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-02-19       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.